Related Experiment Video
Updated: Mar 30, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial
Melinde R S Boland1, Annemarije L Kruis2, Apostolos Tsiachristas3
1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands Institute of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands.
The RECODE disease management program for chronic obstructive pulmonary disease (COPD) in primary care was not cost-effective. It resulted in higher healthcare costs and similar health outcomes, including fewer quality-adjusted life years (QALYs).
Area of Science:
- Health Services Research
- Pulmonology
- Health Economics
Background:
- Chronic obstructive pulmonary disease (COPD) management requires effective and cost-efficient strategies.
- Integrated care models aim to improve patient outcomes and resource utilization in primary care settings.
- The RECODE program was developed to enhance COPD disease management within the Dutch primary care system.
Purpose of the Study:
- To evaluate the cost-effectiveness of the RECODE COPD disease management program compared to usual care.
- To assess the impact of the RECODE program on health outcomes and healthcare costs from both healthcare and societal perspectives.
Main Methods:
- A 2-year cluster-randomised controlled trial involving 1086 patients with COPD across 40 general practices in the Netherlands.
- The intervention group received care from a multidisciplinary team trained in motivational interviewing, care planning, and exacerbation management, supported by an ICT program.
- Health outcomes (QALYs, COPD Questionnaire, St. George's Respiratory Questionnaire, exacerbations) and costs were measured.
Main Results:
- The RECODE intervention incurred additional costs of €324 per patient.
- Healthcare costs were €584 higher and societal costs were €645 higher in the intervention group compared to usual care.
- Health outcomes were comparable between groups, with a slight, statistically significant decrease of 0.04 QALYs in the intervention group.
Conclusions:
- The RECODE integrated care program for COPD in primary care was not found to be cost-effective.
- Professionally directed interventions within this program did not yield sufficient benefits to justify the increased costs.
- Further research may be needed to identify cost-effective COPD management strategies in primary care.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

